Similar articles

• Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.

  Romanova LI, Tolskaya EA, Agol VI. Romanova LI, et al. J Gen Virol. 1981 Feb;52(Pt 2):279-89. doi: 10.1099/0022-1317-52-2-279. J Gen Virol. 1981. PMID: 6169783
• Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.

  Uhlig H, Haardt F, Dernick R. Uhlig H, et al. Arch Virol. 1985;83(3-4):295-303. doi: 10.1007/BF01309924. Arch Virol. 1985. PMID: 2578787
• A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.

  Icenogle J, Gilbert SF, Grieves J, Anderegg J, Rueckert R. Icenogle J, et al. Virology. 1981 Nov;115(1):211-5. doi: 10.1016/0042-6822(81)90103-3. Virology. 1981. PMID: 6270899 No abstract available.
• Approaches to the construction of new candidate poliovirus type 3 vaccine strains.

  Almond JW, Stone D, Burke K, Skinner MA, Macadam AJ, Wood D, Ferguson M, Minor PD. Almond JW, et al. Dev Biol Stand. 1993;78:161-9; discussion 169-70. Dev Biol Stand. 1993. PMID: 8388827 Review.
• The antigenic structure of poliovirus.

  Hogle JM, Filman DJ. Hogle JM, et al. Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):467-78. doi: 10.1098/rstb.1989.0024. Philos Trans R Soc Lond B Biol Sci. 1989. PMID: 2569204 Review.